Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study
Zhu, Yangyang1,2; Meng, Zheling2,3; Wu, Hao1; Fan, Xiao1; Lv, Wenhao1; Tian, Jie2,3; Wang, Kun2,3; Nie, Fang1,4
刊名ULTRASCHALL IN DER MEDIZIN
2023-12-05
页码11
关键词Multimodal Ultrasound Metastatic Cervical Lymphadenopathy Deep Learning Primary Cancer Sites
ISSN号0172-4614
DOI10.1055/a-2161-9369
通讯作者Wang, Kun(kun.wang@ia.ac.cn) ; Nie, Fang(ery_nief@lzu.edu.cn)
英文摘要Purpose To investigate the feasibility of deep learning radiomics (DLR) based on multimodal ultrasound to differentiate the primary cancer sites of metastatic cervical lymphadenopathy (CLA). Materials and Methods This study analyzed 280 biopsy-confirmed metastatic CLAs from 280 cancer patients, including 54 from head and neck squamous cell carcinoma (HNSCC), 58 from thyroid cancer (TC), 92 from lung cancer (LC), and 76 from gastrointestinal cancer (GIC). Before biopsy, patients underwent conventional ultrasound (CUS), ultrasound elastography (UE), and contrast-enhanced ultrasound (CEUS). Based on CUS, DLR models using CUS, CUS+UE, CUS+CEUS, and CUS+UE+CEUS data were developed and compared. The best model was integrated with key clinical indicators selected by univariate analysis to achieve the best classification performance. Results All DLR models achieved similar performance with respect to classifying four primary tumor sites of metastatic CLA (AUC:0.708 similar to 0.755). After integrating key clinical indicators (age, sex, and neck level), the US+UE+CEUS+clinical model yielded the best performance with an overall AUC of 0.822 in the validation cohort, but there was no significance compared with the basal CUS+clinical model (P>0.05), both of which identified metastasis from HNSCC, TC, LC, and GIC with 0.869 and 0.911, 0.838 and 0.916, 0.750 and 0.610, and 0.829 and 0.769, respectively. Conclusion The ultrasound-based DLR model can be used to classify the primary cancer sites of metastatic CLA, and the CUS combined with clinical indicators is adequate to provide a high discriminatory performance. The addition of the combination of UE and CEUS data is expected to further improve performance.
资助项目Beijing Science Fund for Distinguished Young Scholars
WOS关键词SHEAR-WAVE ELASTOGRAPHY ; LYMPH-NODES ; SONOGRAPHY
WOS研究方向Acoustics ; Radiology, Nuclear Medicine & Medical Imaging
语种英语
出版者GEORG THIEME VERLAG KG
WOS记录号WOS:001124362700002
资助机构Beijing Science Fund for Distinguished Young Scholars
内容类型期刊论文
源URL[http://ir.ia.ac.cn/handle/173211/54901]  
专题自动化研究所_中国科学院分子影像重点实验室
通讯作者Wang, Kun; Nie, Fang
作者单位1.Lanzhou Univ Second Hosp, Med Ctr Ultrasound, Lanzhou 730030, Peoples R China
2.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China
3.Univ Chinese Acad Sci Sch, Sch Artificial Intelligence, Beijing, Peoples R China
4.Gansu Prov Med Engn Res Ctr Intelligence Ultrasou, Lanzhou, Peoples R China
推荐引用方式
GB/T 7714
Zhu, Yangyang,Meng, Zheling,Wu, Hao,et al. Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study[J]. ULTRASCHALL IN DER MEDIZIN,2023:11.
APA Zhu, Yangyang.,Meng, Zheling.,Wu, Hao.,Fan, Xiao.,Lv, Wenhao.,...&Nie, Fang.(2023).Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study.ULTRASCHALL IN DER MEDIZIN,11.
MLA Zhu, Yangyang,et al."Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study".ULTRASCHALL IN DER MEDIZIN (2023):11.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace